The Charles Lazarus Children's Abilities Center
New York, 10029, United States
Location status: Recruiting
Location contact
David Putrino
PRINCIPAL_INVESTIGATOR
Jenna Tosto Mancuso, PT, DPT,NCS
CONTACT
NCT Number: NCT07394608
This is an open-label safety and feasibility trial evaluating the use of paired non-invasive vagus nerve stimulation (VNS) and upper extremity (UE) rehabilitation in the motor impairment reduction of adolescent patients with spastic cerebral palsy.
Interested in participating?
Request Info12 year–17 year
All sexes
Interventional
Not applicable
New York, 10029, United States
Location status: Recruiting
David Putrino
PRINCIPAL_INVESTIGATOR
Jenna Tosto Mancuso, PT, DPT,NCS
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Device activates the vagus through the ear. The device is controlled via the Vagustim mobile app, which connects using Bluetooth Low Energy (BLE).
Other names: Non-invasive, transauricular, vagus nerve stimulation device, Vagustim
Time frame: 12 months
Safety is assessed by adverse event.
Time frame: end of therapy visits at Day 46
Number of therapy sessions complete
Time frame: end of therapy visits at Day 46
Number of minutes of training per session
Time frame: end of therapy visits at Day 46
Number of movement repetitions completed per session.
Time frame: baseline Day 1, start of therapy Day 3, end of therapy Day 46, and 3, 6, 9, and 12 months
The Jebsen Taylor Hand Function Test (JTHFT) is a standardized and objective measure of fine and gross motor hand functions that uses simulated activities of daily living (ADLs) assessed by time to completion; typically up to several minutes depending on impairment
Time frame: baseline Day 1, start of therapy Day 3, end of therapy Day 46, and 3, 6, 9, and 12 months
The BOT-2 is a standardized assessment of motor proficiency in children and adolescents. It evaluates fine motor skills, manual dexterity, coordination, and motor integration through structured performance tasks.
Fine Motor Precision (Upper Extremity) scored 0-41, higher score indicates better precision Fine Motor Integration (Upper Extremity) scored 0-45, higher score indicates better integration Manual Dexterity (Upper Extremity) scored 0- 45, higher score indicates better manual dexterity.
Upper-Limb Coordination scored 0-30, higher score indicates better upper-limb coordination.
Time frame: baseline Day 1, start of therapy Day 3, end of therapy Day 46, and 3, 6, 9, and 12 months
ABILHAND is a patient-reported outcome measure that evaluates a person's perceived manual ability to perform daily bimanual activities. It assesses how difficult activities are to perform using both hands.
The ABILHAND-Kids logit score ranges from -6 logits to +6 logits, higher score indicates better bimanual manual ability (tasks are perceived as easier).
Time frame: at 12 months
The PEDI assesses functional abilities and performance in children across three domains: self-care, mobility, and social function. It measures both capability and caregiver assistance.
Subscale range and full range uses scaled scores standardized to a 0-100 metric. Higher scores indicate better functional abilities and greater independence.
Time frame: baseline Day 1, start of therapy Day 3, end of therapy Day 46, and 3, 6, 9, and 12 months
The PedsQL is a standardized patient-reported outcome measure assessing health-related quality of life in children across domains including physical, emotional, social, and school functioning.
Subscales range and full scale scores are transformed to a 0-100 scale. Higher scores indicate better health-related quality of life.
Contact information is provided by the study sponsor or research team.
Icahn School of Medicine at Mount Sinai
Other
Use of Paired Non-Invasive Vagus Nerve Stimulation in Rehabilitation of Adolescents With Cerebral Palsy: An Open Label Safety Feasibility Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01829724
Brain Damage, Chronic, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT06769178
Brain Damage, Chronic, Brain Diseases
Istanbul, Ataşehir, Turkey (Türkiye)
View Trial DetailsNCT07730086
Brain Damage, Chronic, Brain Diseases
Minya, Menia Governorate, Egypt
View Trial DetailsNCT07715006
Brain Damage, Chronic, Brain Diseases
Pittsburgh, Pennsylvania, United States
View Trial Details